Literature DB >> 27020758

Retinal remodeling in human retinitis pigmentosa.

B W Jones1, R L Pfeiffer2, W D Ferrell2, C B Watt2, M Marmor3, R E Marc2.   

Abstract

Retinitis Pigmentosa (RP) in the human is a progressive, currently irreversible neural degenerative disease usually caused by gene defects that disrupt the function or architecture of the photoreceptors. While RP can initially be a disease of photoreceptors, there is increasing evidence that the inner retina becomes progressively disorganized as the outer retina degenerates. These alterations have been extensively described in animal models, but remodeling in humans has not been as well characterized. This study, using computational molecular phenotyping (CMP) seeks to advance our understanding of the retinal remodeling process in humans. We describe cone mediated preservation of overall topology, retinal reprogramming in the earliest stages of the disease in retinal bipolar cells, and alterations in both small molecule and protein signatures of neurons and glia. Furthermore, while Müller glia appear to be some of the last cells left in the degenerate retina, they are also one of the first cell classes in the neural retina to respond to stress which may reveal mechanisms related to remodeling and cell death in other retinal cell classes. Also fundamentally important is the finding that retinal network topologies are altered. Our results suggest interventions that presume substantial preservation of the neural retina will likely fail in late stages of the disease. Even early intervention offers no guarantee that the interventions will be immune to progressive remodeling. Fundamental work in the biology and mechanisms of disease progression are needed to support vision rescue strategies.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Amacrine cell; Bipolar cell; Computational molecular phenotyping (CMP); Cone photoreceptor; Ganglion cell; Müller cell; Neural remodeling; Retina; Retinal pigment epithelium (RPE); Retinal remodeling; Retinitis pigmentosa (RP); Rod photoreceptor

Mesh:

Year:  2016        PMID: 27020758      PMCID: PMC5031517          DOI: 10.1016/j.exer.2016.03.018

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  128 in total

Review 1.  Excitation mapping with the organic cation AGB2+.

Authors:  Robert E Marc; Michael Kalloniatis; Bryan W Jones
Journal:  Vision Res       Date:  2005-09-01       Impact factor: 1.886

2.  Dynamics of arrestin-rhodopsin interactions: acidic phospholipids enable binding of arrestin to purified rhodopsin in detergent.

Authors:  Martha E Sommer; W Clay Smith; David L Farrens
Journal:  J Biol Chem       Date:  2006-01-20       Impact factor: 5.157

3.  Rom-1 is required for rod photoreceptor viability and the regulation of disk morphogenesis.

Authors:  G Clarke; A F Goldberg; D Vidgen; L Collins; L Ploder; L Schwarz; L L Molday; J Rossant; A Szél; R S Molday; D G Birch; R R McInnes
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1.

Authors:  C K Chen; M E Burns; W He; T G Wensel; D A Baylor; M I Simon
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

5.  Responses of rod bipolar cells isolated from the rat retina to the glutamate agonist 2-amino-4-phosphonobutyric acid (APB).

Authors:  M Yamashita; H Wässle
Journal:  J Neurosci       Date:  1991-08       Impact factor: 6.167

6.  Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.

Authors:  H Morimura; G A Fishman; S A Grover; A B Fulton; E L Berson; T P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Photoreceptor ablation initiates the immediate loss of glutamate receptors in postsynaptic bipolar cells in retina.

Authors:  Felice A Dunn
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

8.  Rod photoreceptor neurite sprouting in retinitis pigmentosa.

Authors:  Z Y Li; I J Kljavin; A H Milam
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

9.  Effect of shape and coating of a subretinal prosthesis on its integration with the retina.

Authors:  A Butterwick; P Huie; B W Jones; R E Marc; M Marmor; D Palanker
Journal:  Exp Eye Res       Date:  2008-10-10       Impact factor: 3.467

10.  The AII amacrine cell connectome: a dense network hub.

Authors:  Robert E Marc; James R Anderson; Bryan W Jones; Crystal L Sigulinsky; James S Lauritzen
Journal:  Front Neural Circuits       Date:  2014-09-04       Impact factor: 3.492

View more
  93 in total

Review 1.  Persistent remodeling and neurodegeneration in late-stage retinal degeneration.

Authors:  Rebecca L Pfeiffer; Robert E Marc; Bryan William Jones
Journal:  Prog Retin Eye Res       Date:  2019-07-26       Impact factor: 21.198

2.  Cell type-specific changes in retinal ganglion cell function induced by rod death and cone reorganization in rats.

Authors:  Wan-Qing Yu; Norberto M Grzywacz; Eun-Jin Lee; Greg D Field
Journal:  J Neurophysiol       Date:  2017-04-19       Impact factor: 2.714

Review 3.  Applications of CRISPR/Cas9 in retinal degenerative diseases.

Authors:  Ying-Qian Peng; Luo-Sheng Tang; Shigeo Yoshida; Ye-Di Zhou
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

4.  Changes in intrinsic excitability of ganglion cells in degenerated retinas of RCS rats.

Authors:  Yi-Ming Ren; Chuan-Huang Weng; Cong-Jian Zhao; Zheng-Qin Yin
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

5.  Local photoreceptor degeneration causes local pathophysiological remodeling of retinal neurons.

Authors:  Bristol Denlinger; Zachary Helft; Michael Telias; Henri Lorach; Daniel Palanker; Richard H Kramer
Journal:  JCI Insight       Date:  2020-01-30

6.  Reduction of foveal bulges and other anatomical changes in fellow eyes of patients with unilateral idiopathic macular hole without vitreomacular pathologic changes.

Authors:  Barbara Delas; Gemma Julio; Álvaro Fernández-Vega; Ricardo P Casaroli-Marano; Jeroni Nadal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-23       Impact factor: 3.117

7.  Projection-Resolved Optical Coherence Tomographic Angiography of Retinal Plexuses in Retinitis Pigmentosa.

Authors:  Ahmed M Hagag; Jie Wang; Kevin Lu; Gareth Harman; Richard G Weleber; David Huang; Paul Yang; Mark E Pennesi; Yali Jia
Journal:  Am J Ophthalmol       Date:  2019-03-06       Impact factor: 5.258

8.  NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.

Authors:  Maria Luisa Rocco; Bijorn Omar Balzamino; Graziana Esposito; Carla Petrella; Luigi Aloe; Alessandra Micera
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-24       Impact factor: 3.117

9.  Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.

Authors:  David G Birch; Paul S Bernstein; Alessandro Iannacone; Mark E Pennesi; Byron L Lam; John Heckenlively; Karl Csaky; Mary Elizabeth Hartnett; Kevin L Winthrop; Thiran Jayasundera; Dianna K Hughbanks-Wheaton; Judith Warner; Paul Yang; Gary Edd Fish; Michael P Teske; Neal L Sklaver; Laura Erker; Elvira Chegarnov; Travis Smith; Aimee Wahle; Paul C VanVeldhuisen; Jennifer McCormack; Robert Lindblad; Steven Bramer; Stephen Rose; Patricia Zilliox; Peter J Francis; Richard G Weleber
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

10.  Localized Photoreceptor Ablation Using Femtosecond Pulses Focused With Adaptive Optics.

Authors:  Kamal R Dhakal; Sarah Walters; Juliette E McGregor; Christina Schwarz; Jennifer M Strazzeri; Ebrahim Aboualizadeh; Brittany Bateman; Krystel R Huxlin; Jennifer J Hunter; David R Williams; William H Merigan
Journal:  Transl Vis Sci Technol       Date:  2020-06-16       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.